Clinical Trials Browser

Phase EARLY_PHASE1 × Pathologic Complete Response × Clear all

NCT03832569 2026-03-05

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

Phase EARLY_PHASE1 Active not recruiting

Pathologic Complete Response